Clinical trial
Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under…
NCT00167557 · The University of Texas Health Science Center, Houston, Other · Withdrawn
Key facts
| NCT number | NCT00167557 |
|---|---|
| Title | Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment |
| Official title | Tacrolimus Monotherapy in OLT Recipients With HCV Under Preemptive Treatment With Interferon and Ribavirin |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug, Procedure |
| Interventions | Pegylated Interferon, Ribavirin, Liver Biopsy |
| Enrollment | 0 |
| Start date | Jan 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 14, 2005 |
| Last update posted | Nov 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: